Showing 1 - 17 results of 17 for search 'Sarah T. Hawley', query time: 0.07s
Refine Results
-
1
-
2
-
3
-
4
The Acceptance and Use of Digital Technologies for Self-Reporting Medication Safety Events After Care Transitions to Home in Patients With Cancer: Survey Study by Yun Jiang, Misun Hwang, Youmin Cho, Christopher R Friese, Sarah T Hawley, Milisa Manojlovich, John C Krauss, Yang Gong
Published 2024-03-01
Article -
5
Patient perspectives on factors influencing active surveillance adherence for low‐risk prostate cancer: A qualitative study by Lalita Subramanian, Sarah T. Hawley, Ted A. Skolarus, Aaron Rankin, Michael D. Fetters, Karla Witzke, Jason Chen, Archana Radhakrishnan
Published 2024-01-01
Article -
6
-
7
Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI communit... by Sarah T. Hawley, Kelley Kidwell, David Zahrieh, Anne McCarthy, Rachel Wills, Aaron Rankin, Timothy Hofer, Selina Chow, Reshma Jagsi, Heather Neuman
Published 2023-01-01
Article -
8
Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration by Archana Radhakrishnan, Jennifer Henry, Kevin Zhu, Sarah T. Hawley, Brent K. Hollenbeck, Timothy Hofer, Daniela A. Wittmann, Anne E. Sales, Ted A. Skolarus
Published 2019-05-01
Article -
9
Effects of cancer type and sex on genetic testing for clinician recommendation and uptake by Emerson Delacroix, Erika N. Hanson, Sarah Austin, Grant Carr, Kelley M. Kidwell, Jennifer J. Griggs, Elena Martinez Stoffel, Lynette Hammond Gerido, Sarah T. Hawley, Elizabeth Bacon, Ken Resnicow
Published 2023-12-01
Article -
10
Association between PSA values and surveillance quality after prostate cancer surgery by Christina Hunter Chapman, Megan E. V. Caram, Archana Radhakrishnan, Alexander Tsodikov, Curtiland Deville, Jennifer Burns, Alexander Zaslavsky, Michael Chang, John T. Leppert, Timothy Hofer, Anne E. Sales, Sarah T. Hawley, Brent K. Hollenbeck, Ted A. Skolarus
Published 2019-12-01
Article -
11
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (De... by Ted A. Skolarus, Sarah T. Hawley, Daniela A. Wittmann, Jane Forman, Tabitha Metreger, Jordan B. Sparks, Kevin Zhu, Megan E. V. Caram, Brent K. Hollenbeck, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Vahakn Shahinian, Sriram Srinivasaraghavan, Anne E. Sales
Published 2018-11-01
Article -
12
The Michigan Genetic Hereditary Testing (MiGHT) study’s innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm rand... by Lynette Hammond Gerido, Jennifer J. Griggs, Ken Resnicow, Kelley M. Kidwell, Emerson Delacroix, Sarah Austin, Erika N. Hanson, Elizabeth Bacon, Erika Koeppe, Stefanie Goodall, Matthew Demerath, Elizabeth A. Rizzo, Shayna Weiner, Sarah T. Hawley, Wendy R. Uhlmann, J. Scott Roberts, Elena M. Stoffel
Published 2023-02-01
Article -
13
Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer by Ted A. Skolarus, Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan V. Caram, Lesly Dossett, Alan Paniagua-Cruz, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Brent K. Hollenbeck, Vahakn Shahinian, Anne E. Sales, Daniela A. Wittmann
Published 2021-10-01
Article -
14
Correction: Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer by Ted A. Skolarus, Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan V. Caram, Lesly Dossett, Alan Paniagua-Cruz, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Brent K. Hollenbeck, Vahakn Shahinian, Anne E. Sales, Daniela A. Wittmann
Published 2023-03-01
Article -
15
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study. by Okyaz Eminaga, Wei Wei, Sarah J Hawley, Heidi Auman, Lisa F Newcomb, Jeff Simko, Antonio Hurtado-Coll, Dean A Troyer, Peter R Carroll, Martin E Gleave, Daniel W Lin, Peter S Nelson, Ian M Thompson, Lawrence D True, Jesse K McKenney, Ziding Feng, Ladan Fazli, James D Brooks
Published 2016-01-01
Article -
16
Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies by Ted A. Skolarus, Sarah T. Hawley, Jane Forman, Anne E. Sales, Jordan B. Sparks, Tabitha Metreger, Jennifer Burns, Megan V. Caram, Archana Radhakrishnan, Lesly A. Dossett, Danil V. Makarov, John T. Leppert, Jeremy B. Shelton, Kristian D. Stensland, Jennifer Dunsmore, Steven Maclennan, Sameer Saini, Brent K. Hollenbeck, Vahakn Shahinian, Daniela A. Wittmann, Varad Deolankar, S. Sriram
Published 2024-04-01
Article -
17
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker by Shiqin Liu, Sarah J. Hawley, Christian A. Kunder, En-Chi Hsu, Michelle Shen, Lennart Westphalen, Heidi Auman, Lisa F. Newcomb, Daniel W. Lin, Peter S. Nelson, Ziding Feng, Maria S. Tretiakova, Lawrence D. True, Funda Vakar-Lopez, Peter R. Carroll, Jeffry Simko, Martin E. Gleave, Dean A. Troyer, Jesse K. McKenney, James D. Brooks, Michael A. Liss, Tanya Stoyanova
Published 2024-01-01
Article